Cullinan Therapeutics (CGEM) Insider Trading & Ownership $11.60 +0.65 (+5.94%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cullinan Therapeutics (NASDAQ:CGEM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.07%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.63 M Get CGEM Insider Trade Alerts Want to know when executives and insiders are buying or selling Cullinan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CGEM Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Cullinan Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/18/2024Jennifer MichaelsonInsiderSell4,693$11.41$53,547.13 12/12/2024Jennifer MichaelsonInsiderSell3,489$12.52$43,682.28 11/5/2024Jennifer MichaelsonInsiderSell8,000$15.64$125,120.00 9/5/2024Jennifer MichaelsonInsiderSell8,000$18.09$144,720.00 7/5/2024Jennifer MichaelsonInsiderSell8,000$16.33$130,640.00 5/6/2024Jennifer MichaelsonInsiderSell58,000$28.07$1,628,060.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/1/2024Corrine SavillInsiderSell40,000$16.18$647,200.00 1/29/2024Corrine SavillInsiderSell40,000$14.09$563,600.00 1/22/2024Corrine SavillInsiderSell18,684$12.14$226,823.76 12/26/2023Nadim AhmedCEOSell4,272$9.24$39,473.28 12/21/2023Jeffrey Alan JonesInsiderSell1,860$8.50$15,810.00 12/21/2023Jeffrey TrigilioCFOSell1,920$8.50$16,320.00 (Data available from 1/1/2013 forward) CGEM Insider Trading Activity - Frequently Asked Questions Who is on Cullinan Therapeutics's Insider Roster? The list of insiders at Cullinan Therapeutics includes Bioscience I 2017 Ltd F2, Bvf Partners L P/Il, Corrine Savill, Jeffrey Alan Jones, Jeffrey Trigilio, Jennifer Michaelson, Nadim Ahmed, and Vision Scs F2. Learn more on insiders at CGEM. What percentage of Cullinan Therapeutics stock is owned by insiders? 6.07% of Cullinan Therapeutics stock is owned by insiders. Learn more on CGEM's insider holdings. Which Cullinan Therapeutics insiders have been selling company stock? The following insiders have sold CGEM shares in the last 24 months: Corrine Savill ($1,437,623.76), Jeffrey Alan Jones ($32,603.82), Jeffrey Trigilio ($62,549.89), Jennifer Michaelson ($2,288,493.75), and Nadim Ahmed ($69,597.43). How much insider selling is happening at Cullinan Therapeutics? Insiders have sold a total of 220,016 Cullinan Therapeutics shares in the last 24 months for a total of $3,890,868.65 sold. Cullinan Therapeutics Key ExecutivesMr. Nadim Ahmed (Age 56)President, CEO & Director Compensation: $1.16MDr. Jeffrey Jones M.B.A. (Age 53)M.D., M.P.H., Chief Medical Officer Compensation: $780.32kDr. Patrick A. Baeuerle Ph.D. (Age 66)Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board Compensation: $763.73kMs. Mary Kay Fenton (Age 60)Chief Financial Officer Dr. Jennifer Michaelson Ph.D. (Age 57)Chief Scientific Officer Ms. Jacquelyn L. Sumer J.D. (Age 46)Chief Legal Officer, Chief Compliance Officer & Corporate Secretary Ms. Rose WeldonSenior Vice President of CommunicationsMr. Steve AndreChief Human Resources OfficerDr. Corinne Savill Ph.D. (Age 65)Chief Business Officer Mr. Kevin A. JohnstonChief Technical Operations Officer More Insider Trading Tools from MarketBeat Related Companies Bausch Health Companies Insider Transactions Arrowhead Pharmaceuticals Insider Transactions Dyne Therapeutics Insider Transactions Catalyst Pharmaceuticals Insider Transactions Agios Pharmaceuticals Insider Transactions Protagonist Therapeutics Insider Transactions Iovance Biotherapeutics Insider Transactions Amneal Pharmaceuticals Insider Transactions Longboard Pharmaceuticals Insider Transactions NewAmsterdam Pharma Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:CGEM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
